tiprankstipranks
Quantum Biopharma (QNTM)
NASDAQ:QNTM
US Market
QNTM
Quantum Biopharma
RESEARCH TOOLSreports
Want to see QNTM full AI Analyst Report?

Quantum Biopharma (QNTM) Income Statement

629 Followers

Quantum Biopharma Income Statement

Last quarter (Q4 2023), Quantum Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Quantum Biopharma's net income was $―. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Aug 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 4.54M$ 4.11M$ 3.90M$ ―
EBITDA
$ ―$ -22.57M$ -29.09M$ -24.46M$ -19.37K
Operating Income
$ -19.23M$ -27.48M$ -33.81M$ -30.69M$ -19.37K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
 ― ― ― ― ―
Weighted Average Shares Outstanding (Diluted)
 ― ― ― ― ―
Currency in USD

Quantum Biopharma Earnings and Revenue History